Glycomine raises $115M to target rare glycosylation disordernews2025-04-16T11:00:23+00:00April 16th, 2025|Endpoints News|
Attovia collects another $90M for I&I biologics in third funding round in two yearsnews2025-04-15T11:30:13+00:00April 15th, 2025|Endpoints News|
Small biotech Oak Hill will bring Roche’s Angelman drug back to lifenews2025-04-15T11:00:21+00:00April 15th, 2025|Endpoints News|
BioNTech-backed ADC maker DualityBio plans Hong Kong IPOnews2025-04-14T19:23:17+00:00April 14th, 2025|Endpoints News|
Recruiters say some biopharmas pause hiring as they struggle to make sense of ongoing uncertaintynews2025-04-11T15:19:31+00:00April 11th, 2025|Endpoints News|
Exclusive: Cardiometabolic biotech gets $57.5M Series B, with help from Cytokineticsnews2025-04-10T11:00:19+00:00April 10th, 2025|Endpoints News|
Biotech market meltdown will leave some startups looking at survival playbooknews2025-04-09T15:00:42+00:00April 9th, 2025|Endpoints News|
Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their rootsnews2025-04-08T11:00:37+00:00April 8th, 2025|Endpoints News|
ADC startup DualityBio seeks Hong Kong IPO amid precarious marketnews2025-04-07T11:35:57+00:00April 7th, 2025|Endpoints News|
